Search
Search Results
##search.searchResults.foundPlural##
-
WALDENSTROM’S MACROGLOBULINEMIA: AN UPDATE
7924PDF: 2506HTML: 2139Table 1.: 268Table 2.: 275Table 3.: 258Table 4.: 254 -
OCCURRENCE OF SECONDARY MALIGNANCIES IN CHRONIC MYELOID LEUKEMIA DURING THERAPY WITH IMATINIB MESYLATE-SINGLE INSTITUTION EXPERIENCE
2389PDF: 1114HTML: 2030Characteristic of study group: 237 -
THE SPECTRUM OF GENETIC DEFECTS IN CHRONIC LYMPHOCYTIC LEUKEMIA
2359PDF: 931HTML: 2020Fig 1 Rossi: 241 -
-
HISTORY OF ACUTE PROMYELOCYTIC LEUKEMIA: A TALE OF ENDLESS REVOLUTION
3312PDF: 1166HTML: 1959 -
APLASTIC ANEMIA AND VIRAL HEPATITIS
1337PDF: 561HTML: 23219 -
LIMITED STAGE FOLLICULAR LYMPHOMA: THE ROLE OF RADIATION THERAPY.
3822PDF: 1166HTML: 2482Figure 1: 240 -
SICKLE CELL DISEASE AND VENOUS THROMBOEMBOLISM
2370PDF: 985HTML: 2313 -
INTEREST IN DETERMINING THE CD34+ CD38- PHENOTYPE IN THE DIAGNOSIS AND PROGNOSIS OF ACUTE LEUKEMIA IN ABIDJAN – CÔTE D’IVOIRE
2085PDF: 804HTML: 726Table1: patient's characteristics: 198Table 2: profile of each patient: 216 -
Toxic epidermal necrolysis associated with severe cytomegalovirus infection in a patient on regular hemodialysis.
1847PDF: 599HTML: 16999Figure 4: 210Figure 3: 176Figure 2: 182Figure 1: 217 -
MEDICAL TREATMENT OF HEPATOCELLULAR CARCINOMA
775PDF: 493HTML: 6287 -
THE PROTHROMBOTIC STATE ASSOCIATED WITH SARS-COV-2 INFECTION: PATHOPHYSIOLOGICAL ASPECTS COVID and Thrombosis
2409PDF: 869HTML: 482 -
NOVEL DRUGS IN FOLLICULAR LYMPHOMA
5878PDF: 1595HTML: 1667Untitled: 276 -
VON WILLEBRAND FACTOR, ANGIODYSPLASIA AND ANGIOGENESIS
3912PDF: 1659HTML: 8244Randi Fig: 221 -
TYROSINE KINASE INHIBITORS AND INTERFERON
2988PDF: 1500HTML: 3102Cover Letter: 251 -
Kikuchi-Fujimoto disease and hemophagocytic lymphohistiocytosis: a rare combination of two rare diseases
997PDF: 724Suppl. Files: 151HTML: 166 -
CLINICAL ASPECTS AND THERAPY OF SPORADIC BURKITT LYMPHOMA
1400PDF: 635HTML: 4179 -
PERPHERAL BLOOD CELL MITOCHONDRIAL DYSFUNCTION IN MYELODYSPLASTIC SYNDROMECAN BE IMPROVED BY A COMBINATION OF COENZYME Q10 AND CARNITINE Blood cell mitochondrial dysfunction in myelodysplastic syndrome
1316PDF: 835HTML: 405 -
DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES: ANALOGIES AND DIFFERENCES DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES
1632HTML: 685PDF: 904 -
FDG-PET SCAN: A NEW PARADIGM FOR FOLLICULAR LYMPHOMA MANAGEMENT.
3411PDF: 1326HTML: 2369 -
PATHOGENESIS OF MALARIA IN TISSUES AND BLOOD
4735PDF: 2022HTML: 18178 -
DEFERASIROX: OVER A DECADE OF EXPERIENCE IN THALASSEMIA
3273PDF: 1681HTML: 371 -
IMMUNOLOGICAL DEREGULATION IN HODGKIN’S DISEASE
2310PDF: 1039HTML: 1986 -
EBV-RELATED LYMPHOPROLIFERATIVE DISEASES: A REVIEW IN LIGHT OF NEW CLASSIFICATIONS EBV-RELATED LYMPHOPROLIFERATIVE DISEASES
4651PDF: 1803HTML: 1291 -
ARA-C, IDARUBICINE AND GENTUZUMAB OZOGAMICIN (AIM) AS SALVAGE TREATMENT IN ADVANCED ACUTE MYELOID LEUKEMIA PATIENTS
1756PDF: 867HTML: 968cover letter: 322 -
CONCISE REVIEW ON THE FREQUENCY, MAJOR RISK FACTORS AND SURVEILLANCE OF HEPATOCELLULAR CARCINOMA (HCC) IN ?-THALASSEMIAS: PAST, PRESENT AND FUTURE PERSPECTIVES Thalassaemia transfusion dependent, Hepatitis C, hepatocarcinoma.
4417PDF: 1591HTML: 478 -
EVALUATION OF THE PLASMA MICRO RNA EXPRESSION LEVELS IN SECONDARY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS
1485PDF: 741HTML: 1190Untitled: 217Untitled: 181Untitled: 168Untitled: 187Untitled: 201 -
HEPATITIS C VIRUS INFECTION AND LYMPHOMA
1124PDF: 656HTML: 7883 -
High Prevalence of Antiphospholipid Antibodies in Children with Non-Transfusion Dependent Thalassemia and Possible Correlations with Microparticles Antiphospholipid Antibodies and Thalassemia in children
1110PDF: 666HTML: 321







